A protein displaying significant similarity to mammalian HMGA (high-mobility group A) proteins, but also bearing unique structural features, was isolated from silkmoth (Bombyx mori) follicular cells. This factor, named BmHMGA, exhibits specific binding preference for chorion gene promoter elements and induces DNA bending thereon. BmHMGA deploys temporalspecific interaction with transcription factors BmC/EBP (C/EBP is CCAAT/enhancer-binding protein) and BmGATAβ during follicle maturation. The respective protein complexes can be detected on chorion gene promoters in vivo, with different developmental profiles each time. Analogous interaction takes place on the putative promoter of the BmC/EBP gene, hinting towards a transcriptional circuit that is responsible for the progress of choriogenesis as a whole. Finally, transient suppression of BmHMGA expression led to down-regulation of chorion genes and the BmC/EBP gene, and revealed recruitment of BmC/EBP, BmGATAβ and TFIID (transcription factor IID)/TBP (TATAbox-binding protein) by BmHMGA. A revised model for chorion gene regulation is discussed in view of these findings.
INTRODUCTION
In eukaryotes, developmental regulation of gene expression in response to environmental or physiological stimuli renders cascades of promoter activation very complex. Our need to thoroughly understand such molecular processes requires a suitable system of study. The developing silkmoth (Bombyx mori) ovariole represents an established model for studies on differential gene expression during the execution of long-term developmental programmes, with all stages of follicular development being organized in a continuous array [1] . The final process of B. mori oogenesis is choriogenesis and results in the formation of chorion; this complex protein structure surrounds the oocyte and develops alongside it. Being expressed solely in the follicular cells surrounding the developing oocyte, chorion genes are regulated through a sequence of gene activation and repression events [1] . According to their time of expression, chorion genes are characterized as E (early) (5H4, ErA/B, 6F6), M (middle) (A/B) or L (late) (HcA/B) [2] [3] [4] [5] . The respective superfamily consists of α and β genes; α and β genes of the same developmental specificity are in their vast majority organized in divergently transcribed pairs, sharing a common 5 -flanking promoter region [2, 3, 6] . These relatively short intergenic sequences (approx. 250 bp) are equipped with all cis-elements required for differential gene regulation [7] . Transcriptional cascades responsible for tissue and temporal specificity are thought to involve several transcription factors in various combinations during different phases of choriogenesis [8] [9] [10] .
In the present study, we identified yet another protein factor which participates in the formation of multiprotein complexes on chorion gene promoters. We characterized this molecule as a member of the non-histone HMG (high-mobility group) protein family. HMG proteins, often termed 'architectural factors', are relatively abundant and ubiquitous; they are classified into three subfamilies: HMGA (HMGI/Y and HMGC), HMGB (HMG-1 and HMG-2) and HMGN (HMG14 and HMG17), following the revised nomenclature of [11] .
Proteins of the HMGA subfamily [12] , originally characterized by their small molecular size (10-13 kDa), associate with DNA via minor groove interactions by utilizing a set of DNA-binding domains (AT-hooks) located close to their N-terminus. The interacting counterparts for efficient binding are the characteristic basic AT-hook motif (G/P-R-G-R-P, core consensus) and an approx. 10 bp A/T-rich DNA sequence [13] . Functionally, HMGA proteins, although not potent activators on their own, play a key role in the transcriptional activation of numerous genes by inducing conformational changes to DNA in vivo and by mediating transcription factor recruitment and interaction [12, 14, 15] . Contortion in DNA structure is thought to facilitate deployment of additional DNA-protein or protein-protein contacts, which, in the absence of such bending-induced compaction, would not be feasible [16] .
In insects, proteins belonging to the HMG family have been biochemically characterized in the dipterans Drosophila and Chironomus [17, 18] , whereas analogous lepidopteran factors have only been discovered more recently [19] . In the present study, we analyse the functional properties of the novel B. mori HMGA protein by focusing on how the EM (early-middle)/M A/B.L9 and the M/ML (middle-late) A/B.L1 chorion gene pairs are differentially regulated, with their expression profile and promoter architecture displaying only subtle differences. We offer evidence for BmHMGA (Bm is B. mori) implication in chorion gene regulation via interaction with BmC/EBP (C/EBP is CCAAT/enhancer-binding protein) and BmGATAβ; a revision of the model for evoking transcriptional activation and imposing repression of chorion gene expression [9, 10] is discussed accordingly.
EXPERIMENTAL
Animal strains, follicle staging, and preparation of nuclear extracts A total of 100 female pupae of the B. mori FengIx54A strain were dissected 8 days after pupation. Isolation of intact developing ovarioles was followed by follicle staging [20] . Vitellogenic follicles were pooled together (Pre), and choriogenic follicles were divided into six consecutive developmental stages [E, EM, M, ML, L and VL (very late)]. Nuclear extracts from staged follicular cells were prepared as described previously [21] .
Generation of cladograms
Neighbour-joining cladograms were generated using Molecular Evolutionary Genetic Analysis software 3.0 [22] . Bootstrap test values were set at 1050 for 'replication' in the Poisson correction analysis applied.
Northern blot analysis
Total RNA was isolated from pooled late vitellogenic and choriogenic follicles using TriPure (Roche); poly(A)
+ RNA was obtained with the Oligotex purification kit (Qiagen). Following electrophoresis, the sample was transferred on to a nylon membrane (GE Healthcare) using a capillary device. Prehybridization and hybridization were carried out in 0.4 M NaCl, 50 mM Tris/HCl (pH 7.5), 1 % SDS, 5 mM EDTA, 12× Denhardt's solution (0.02 % Ficoll 400, 0.02 % polyvinylpyrrolidone and 0.02 % BSA) and 0.5 mg/ml salmon sperm DNA at 67
• C overnight. The full-length BmHMGA cDNA probe was labelled by random priming (Fermentas); the High Range RNA ladder (Fermentas) was used.
Quantitative real-time PCR
Transcription levels for BmHMGA and BmC/EBP were assessed using quantitative real-time PCR (Applied Biosystems 7500 series). Reactions were carried out in triplicate on two separately obtained poly(A) + RNA templates from staged follicles; the set up was repeated twice. For the Δ(Δ Ct ) method, chosen calculations were carried out according to the manufacturer's instructions (ABI Guide to Performing Relative Quantitation of Gene Expression). Primers were designed using the Primer Express 3.0 software (qHMGA-F, 5 -caagggcaagggtgaaggta-3 , and qHMGA-R, 5 -ttcctcagtagaagcagcatctttt-3 , and qC/EBP-F, 5 -ccccaaccagacctcaaaaa-3 , and qC/EBP-R, 5 -gtccattgagctcgtcgagtt-3 ); actin amplification served as reference.
Expression and purification of His 6 -tagged fusion proteins
ORFs (open reading frames) for the wild-type and deletion mutants of BmHMGA were generated via PCR (HMGexpF, 5 -ccatatgtctgacgacggttcaacag-3 , and HMGexpR, 5 -gggatccttattggtcttcagatccttcatc-3 , HMGmutF1, 5 -ccatatggccaatggaacacaacctgagtcg-3 , and HMGmutF2, 5 -ccatatggctgccaccagaacaaaag-3 , and HMGmutR1, 5 -gggatccttacttgactcccgcttttttcttgga-3 , and HMGmutR2, 5 -gggatccttacctgttcttcctcagtagaagcagc-3 ). Underlined sequences indicate restriction endonuclease sites. Amplified products were cloned into the pET15-b expression vector (Novagen) and ORF integrity was confirmed by DNA sequencing (MWG-Biotech A.G.). Proteins were expressed as His 6 -tagged fusions in the Escherichia coli BL21(DE3) strain (Novagen) and affinity-purified from an Ni-NTA (Ni 2+ -nitrilotriacetate) resin column (Qiagen) to near homogeneity under native conditions. Samples were dialysed against 350 mM NaCl, 20 mM Hepes (pH 7.9), 10 mM KCl, 1.5 mM MgCl 2 , 0.1 mM EGTA, 10 % glycerol, 0.5 mM DTT (dithiothreitol) and 0.5 mM PMSF.
Gel retardation assays
Approx. 2 × 10 4 c.p.m. (corresponding to an average of 5 ng) of the appropriate probe was incubated with follicular nuclear extracts or bacterially produced proteins and loaded on to 6 % non-denaturing polyacrylamide gels as described previously [21] . The pL1 and pL9 fragments representing the A/B.L1 and A/B.L9 promoter regions located between the α-and β-TATA boxes were used as probes. All promoter fragments were end-labelled by filling in 3 -protruding ends with [α-32 P]ATP using Klenow fragment (Fermentas). For competition assays double-stranded oligonucleotides were added in a 100 × molar excess. For supershift assays, the antiserum raised against full-length human HMGI(Y) and its corresponding pre-immunization serum were used.
DNase I footprinting assays
After radiolabelling each strand of the pL1 or pL9 fragment separately, 10 5 c.p.m. of the appropriate probe was mixed with recombinant BmHMGA and treated with 200-400 ng of DNase I; for control reactions, the same amount of probe was cleaved with 100-200 ng of DNase I. All other procedures were as described previously [21] .
Circular permutation analysis
Restriction fragments derived from the digestion of pL1, pL9, α-and βL9/pBend2 constructs with ClaI, SspI, EcoRV, PvuII, BglII, SmaI or BamHI (NEB) were end-labelled using [γ -32 P]ATP (Fermentas). Gel retardation assays were carried out as described above. Plots and calculations were carried out as described in [23] . Briefly, the relative electrophoretic mobility of the observed complexes was calculated as the fraction of complex mobility to the mobility of the unbound probe, in order to correct for intrinsic variations in DNA mobility. Relative mobilities were then plotted as a function of the distance of each fragment from the left-hand end of the SmaI restriction site. Bend centres were estimated under the assumption that middle-bound (or nearly middle-bound) protein-DNA complexes are the slower-migrating ones [24] . Extrapolation of the linear portions of each curve revealed the bending point on the DNA substrate. Assays were performed twice to ensure reproducibility.
Yeast two-hybrid interaction assays
Interaction assays were carried out using the MATCHMAKER System 3 in the AH109 yeast strain (Clontech) according to the manufacturer's instructions. In brief, full-length ORFs of BmC/EBP, BmGATAβ and BmHMGA were cloned into the pGBKT7-bait and pGAD424-prey vectors and were used for simultaneous transformation of competent yeast cells; 'bait' constructs were checked for self-activation of the reporter gene and yielded no detectable activity. After being grown in selective medium [−Ade (adenine)/−Trp/−Leu/−His], interaction potency was evaluated by measuring absorbance at 420 nm, using ONPG (o-nitrophenyl β-D-galactopyranoside) (Pierce) as substrate. The pVA3-pTD1 interaction was used as a positive interaction control (Clontech); interaction of BmHMGA with the bracovirus protein CcV1 was used to determine a noninteraction threshold.
Co-immunoprecipitation assays and Western blotting
Staged follicular nuclear extracts (250 μg) were incubated overnight at 4
• C in the presence of 25 mM Tris/HCl (pH 7.5), 125 mM NaCl, 1 × anti-protease cocktail (Macherey Nagel) and the appropriate antiserum. Complexes were washed twice in high salt (500 mM NaCl) and low salt (0 mM NaCl) and precipitated using Protein A-agarose (Roche). Following SDS/PAGE in 11-18 % gradient gels, samples were transferred on to nitrocellulose filters (Schleicher & Schuell) using the TE70 Semiphor Unit according to the manufacturer's instructions (Pharmacia). After overnight incubation with appropriate antibodies (diluted 1/1000), membranes were washed and subsequently incubated with the HRP (horseradish peroxidase)-conjugated anti-(rabbit IgG) antibody (Sigma) (dilution 1/40 000). Specific signals were detected using the SuperSignal West Pico substrate system (Pierce); the Benchmark pre-stained protein marker (Invitrogen) was used.
In vitro interaction assays via chemical cross-linking
Equimolar quantities (approx. 5 nmol) of recombinant BmHMGA, BmC/EBP, BmC/EBPγ and BmHMGA deletion mutants (mut2-mut5) were allowed to interact overnight at 4
• C in 20 mM Hepes (pH 7.9), 200 mM NaCl, 10 mM KCl, 10 mM MgCl 2 and 1 × anti-protease cocktail. Formed protein complexes were cross-linked by the addition of 2 mM BS 3 [bis(sulfosuccinimidyl) suberate] (Pierce). After incubation at room temperature (25 • C) for 25 min, reactions were quenched in 50 mM Tris/HCl (pH 7.5). Samples were consecutively analysed by SDS/PAGE (16 % gels) and transferred on to nitrocellulose membranes. In Western blots, all proteins and complexes were simultaneously identified by a monoclonal anti-(His 6 tag) antibody (2365; Cell Signaling Technology). Assays were performed in triplicate to ensure reproducibility.
ChIP (chromatin immunoprecipitation) assays
ChIP assays were performed as described previously [25] . Antibodies used were: anti-HMGA raised against the full-length human HMGI/(Y); C135 raised against Drosophila C/EBP; NT2-102 recognizing BmGATAβ; anti-TFIID (transcription factor IID) (58C9X, Santa Cruz Biotechnology); and anti-C/EBPδ (sc-151X, Santa Cruz Biotechnology) for the non-specific control. Assays were performed twice on separately isolated templates.
Antisense DNA interference
Antisense DNA assays were performed essentially as described in [26] . Briefly, a 4-day-old pupa was dissected, and follicles corresponding to vitellogenic (− 10 to − 6, Series A) and to E choriogenic stages (+ 1 to + 5, Series B) were collected and allowed to develop ex vivo in appropriate medium (Grace's insect medium: 0.5 % fetal calf serum and 50 mg/ml gentamycin) and environment (28 • C, 100 % oxygen atmosphere). Different concentrations (0-25 μM) of a phosphorothioatemodified oligonucleotide (BmHMGA-AS, 5 -gtcagacatagttcactaaa-3 ), which spanned 20 nucleotides around the initiation codon of the BmHMGA transcript, were added to the culture medium, which was renewed every 12 h. The incubation time was 36 h in total. For the mock assay (mock oligonucleotide, 5 -tttagtgaactatgtctgac-3 ), vitellogenic and E choriogenic follicles were pooled together. The interference effect was assessed through RT (reverse transcription)-PCR using Superscript II (Invitrogen). Primer sets used were: HMGexpF and BmHMGexpR (restriction sites omitted); BmC/EBPF, 5 -gagcgtcctacgcgccagtac-3 , and BmC/EBPR, 5 -gatcacggagctgtgccggtc-3 , Er.A1F, 5 -ctacattcgctgtcttactcctttgc-3 , and Er.A1R, 5 -gcacctgtcccattacaccgg-3 , B.L11F, 5 -gtggcacagccgctttaggc-3 , and B.L11R, 5 -ccgtagccgcctccgtaac-3 , and ActinF, 5 -gacgaagaagttgccgcgttgg-3 , and ActinR, 5 -ggcgggcgtgttgaatgtttcg-3 . Assays were performed twice to ensure reproducibility.
RESULTS

Structural features and developmental profile of BmHMGA
The uncharacterized BmMCBP5 cDNA sequence [1] was used to design specific primers for PCR on an E choriogenic follicular cell cDNA library template [9] . This resulted in the amplification of a single 343 bp fragment. The full-length clone, named BmHMGA (GenBank ® accession number DQ402512), was subsequently isolated via PCR (Herculase II, Stratagene) using 5 or 3 universal primers of the library vector (Clontech). Sequence analysis revealed 1205 bp containing an ORF coding for a putative polypeptide of 114 amino acids. The latter was found to include characteristic motifs of the HMG protein family: four AT-hook motifs, three of which follow the same amino acid core consensus (Gly-Arg-Gly-Arg-Pro), whereas, in the second one, the first glycine residue was replaced by lysine. In the protein C-terminus, a stretch of acidic residues was identified, another common feature of HMG proteins ( Figure 1 ). In order to classify the B. mori protein, its sequence was aligned against other invertebrate and vertebrate HMG protein sequences. In the neighbour-joining cladogram produced, this novel factor was positioned closer to mammalian HMGA proteins; protein sequences derived from Drosophila and Aedes formed a different outgroup ( Figure 2A ). The BmHMGA number of AT-hook motifs is not encountered in any animal HMGA protein, but appears to be a characteristic feature of the respective plant factors [27] . These proteins are significantly larger (170-210 amino acids long) than their animal counterparts, owing to the insertion of a N-terminal globular domain. The Triticum aestivum-and Oryza sativaderived proteins (GenBank ® accession numbers AF502250 and BAC24935 respectively) were also not grouped with BmHMGA, since similarity regarding the AT-hook number and amino acid composition did not extend to the rest of the protein sequence. The aforementioned features underline a close association of BmHMGA with homologues derived from higher vertebrates and accentuate its differentiation in primary structure and motif composition from any animal HMG factor isolated to date.
In silico screening of the B. mori genomic database (http://sgp.dna.affrc.go.jp/) using the cDNA clone as probe revealed the organization of the BmHMGA gene; numerous overlapping contigs were retrieved. Analysis allowed the identification of two intronic sequences (66 bp each, Figure 1 ) in the ORF, positioned 72 and 225 bp from the initiation codon respectively. These introns separate the coding region into three exons, each one containing a single AT-hook motif, with the exception of the second and third motifs which are situated in the same exon. An additional 574 bp intron was found in the 5 -untranslated region, spanning positions + 509 to + 1083; a similar feature exists in the human HMGA1 gene, but is absent from the mouse Hmga1 gene [28] . These findings raise the possibility of alternative splicing, since mammalian HMGA1a and HMGA1b result from a single transcript [29] ; this was investigated by Northern blot analysis. Vitellogenic and total choriogenic follicles were probed with the full cDNA sequence and resulted in a single 1.3 kb band ( Figure 2B) ; it can be thus inferred that BmHMGA is present as a single transcript throughout oogenesis. Screening of the B. mori EST (expressed sequence tag) database (http://morus.ab.a.u-tokyo.ac.jp/cgi-bin/index.cgi) for BmHMGA transcripts revealed its wide dispersion in almost all available libraries (results not shown), indicative of a ubiquitously expressed factor. In an effort to correlate the BmHMGA transcription profile with that of BmC/EBP, a molecule of key importance for chorion gene regulation [9, 10] , we carried out quantitative real-time PCR for both transcripts using mRNA from staged follicles. Comparative analysis showed that BmC/EBP exhibited higher expression levels during E-EM stages, followed by a decline towards L choriogenesis (in agreement with RNA dot blot [9] ); BmHMGA displayed significantly higher expression levels in three distinct peaks: during vitellogenesis, in mid-choriogenesis and in VL choriogenic stages ( Figure 2C ).
Specific binding to chorion gene promoters occurs via two AT-hooks
Binding of HMG proteins to DNA is mediated by AT-hook motifs and preferably occurs on A/T-rich sequences of the minor groove [12] . We tested bacterially produced BmHMGA for binding to chorion gene promoter fragments. In gel retardation assays, recombinant BmHMGA was allowed to interact with radiolabelled promoter fragments pL1 and pL9 from the A/B.L1 and A/B.L9 chorion gene pairs respectively ( Figure 3A) . Binding was evident even when the factor was added in small amounts (100 ng; 1:8 DNA/protein molar ratio), whereas larger amounts of protein (1:25 and 1:40 molar ratios) resulted in complexes of gradually decreasing mobility. This suggests either multiple HMGA-binding sites on these promoters or non-specific interaction. Supershift assays using an HMGA antiserum resulted in lowered complex mobility, thus verifying involvement of this factor in the observed protein-DNA interaction ( Figure 3B ). Direct binding of BmHMGA was also observed on promoter fragments derived from chorion genes of E and L specificity (results not shown). Substrate preference was assessed using synthetic double-stranded polynucleotides as competitors in gel retardation assays ( Figure 3C ). Given that HMG family members are prone to binding A/T-rich sequences, we tested poly(dAdT)·(dA-dT) and poly(dG-dC)·(dG-dC) substrates. BmHMGA-DNA complexes responded differently to each competitor. We observed increased sensitivity to poly(dA-dT)·(dA-dT): the complex dissociated completely in the presence of 500 ng of the competitor, whereas treatment with poly(dG-dC)·(dG-dC) did not produce any obvious effect.
We also investigated the manner by which BmHMGA recognizes and binds chorion gene promoters via DNase I footprinting assays on the pL1 and pL9 promoter fragments ( Figure 4 ). Footprints revealed involvement of two 10-12 bp sequences on each promoter (L1-I and L1-II, and L9-I and L9-II). All four sequences are A/ T-rich; spacer sequences are largely composed of pyrimidines. Type I binding elements follow a 5 -ARARWAAYYTYT-3 consensus sequence, whereas type II elements have a 5 -WAKYATTTW-3 consensus. Both BmHMGA recognition sequence pairs are located closer to the α-gene and are spaced apart by approximately half and one-and-a-half turns of the DNA helix for pL1 and pL9 respectively. Projection of the sites on the double-stranded DNA revealed that each pair resides on the same side of the helix. Such phasing of cis-elements has been established as a prerequisite for binding of a single HMGA molecule via two consecutive AT-hooks [15] . Although a single AT-hook motif may bind DNA as a monomer (see mut5 in Figure 7 ), it is possible that footprints I and II represent binding sites for two adjacent AT-hooks of BmHMGA. In the case of pL1, the intervening distance between the two sequences may be easily covered by the amino acid stretch connecting adjacent AT-hooks of BmHMGA, the shortest being 20 amino acids long. For pL9 the one-and-a-half turns of the helix would require a connecting sequence of approx. 30 amino acids. This would require involvement of either the second and third AT-hook pair of BmHMGA (centre to centre distance is 29 amino acids) or the cooperation of two non-consecutive motifs; an alternative scenario could be binding to a pre-bent DNA structure [29] , which would decrease the distance to be covered.
In pL1, the type I and II sites are tightly associated with an L-type C/EBP site, and in pL9, an E-type C/EBP site [9] is Figure 5A ), the BmHMGA-pL9 complex was abolished when the non-radiolabelled L9-II fragment was added to the reaction. This finding suggests comparable affinity of BmHMGA binding to L9-I and L9-II elements and is also supported by the fact that both footprints were generated simultaneously upon addition of BmHMGA (Figure 4) . We should stress that in both 1:8 and 1:40 DNA/protein molar ratios used for footprinting, no additional protected sequences could be identified. We therefore attribute slower migrating complexes seen in gel retardation assays to non-specific protein-protein contacts, due to protein excess. Using the actin A3 promoter region (GenBank accession number AF422795) or the C/EBP binding element (oX2) as competitors, protein-DNA complex formation was not affected. When pL9 was allowed to interact with EM follicular nuclear extracts, formation of six distinct complexes was observed ( Figure 5A ). Although complexes X1-X5 could be competed out by the C/EBP-binding element oX2, the X5 complex was also abolished by the addition of L9-II to the reaction. This suggests BmHMGABmC/EBP synergy during complex formation. Enhancement of the G (GATA) complex upon dissociation of X-complexes suggests an antagonistic binding mode between BmC/EBP and BmGATAβ (also observed in E chorion genes [21] ). Both C/EBP and HMGA proteins are characterized by heat stability [9, 30, 31] . This was affirmed for BmHMGA by heating at 70
• C for 10 min and proceeding with gel retardation assays, where the factor retained functionality despite thermal shock. Furthermore, preheating EM follicular nuclear extracts did not affect X-complex formation ( Figure 5A ).
Full-length BmHMGA induces specific bending on chorion gene promoters
Members of the HMG family have been known to induce bends of 70-130
• to double-stranded DNA [32, 33] . Nevertheless, HMGA proteins were not thought to induce specific bends, but rather to retain proper B-DNA geometry and in cases reverse moderately pre-bent structures [13] . In order to examine the bending potential of BmHMGA, we prepared constructs of pL1 and pL9 in the pBend2 vector [30] . Circularly permuted restriction fragments of the same length were generated from pBend2 constructs. As has been established, binding of a protein to its cognate cis-element, borne on a DNA fragment, retards the mobility of the fragment during gel electrophoresis. If protein binding also results in DNA bending, one should expect alterations in complex migration during electrophoresis, since this is affected by the position and degree of the bend induced [34] . Gel retardation assays revealed differences in the mobility of pL1 and pL9 permuted fragments. Control electrophoresis of the probes in the absence of BmHMGA or in the presence of a Chd1-like B. mori protein which also contained AT-hook motifs did not produce differentially migrating bands (A. Papantonis and R. Lecanidou, unpublished work). The above results provide evidence of BmHMGA-induced specific DNA bending of chorion gene promoters.
The altered electrophoretic mobility of each curved fragment may be attributed to the reduction in its end-to-end distance [24] : when the bending site is located near the middle of the DNA fragment, mobility is less than when it is closer to either end. The relative mobility of each complex was calculated and plotted against the relative position of the restriction fragment ( Figure 6A ). In general, if only one major bending locus appears in a DNA fragment, the mobility curve should be symmetrical and roughly sinusoidal with a period equal to the length of the fragment [35] . Extrapolation of the linear portions of the curves pointed to the bending locus on the construct. For pL1, this is located approx. 67 bp upstream of the 5 -end of the XbaI cloning site, and, for pL9, 78 bp upstream of the same site. This could be translated into a locus of curvature located in both cases between the type I and II cis-elements that BmHMGA recognizes (shown in Figures 4 and 6A) . In order to confirm bending point estimates, we subcloned the α-and β-halves of the pL9 promoter region into the pBend2 vector and used permuted restriction fragments (SspI, EcoRV, PvuII, BglII) in bending assays ( Figure 6B ). Noticeably, complex mobility was Figure 5 Gel retardation assays using BmHMGA, BmC/EBP and follicular nuclear extracts (A) Competition assays using oligonucleotides that represent characterized cis-elements. The pL9 promoter fragment (free probe, lanes 1 and 7) was allowed to interact with BmHMGA (300 ng, lanes 2-5) and follicular nuclear extracts from EM stages (4 μg, lanes 6 and 8-10) in the absence (lanes 5, 6 and 9) or presence of non-labelled competitors representing the L9-II-binding site (lanes 2 and 10), the C/EBP-binding site from the 6F6.2 gene promoter (oX2, lanes 3 and 8), the actin A3 promoter (lane 4). Pre-heated extracts were used in lanes 5 and 9 (70 • C for 10 min). (B) In vitro BmHMGA-BmC/EBP binding synergy. Proteins were added to the binding reaction in a 1:1 molar ratio (300 and 850 ng respectively) independently (lanes 2 and 3), sequentially (lane 4) or simultaneously. In all panels, complexes formed are indicated with X-for unknown consistency, C-for C/EBP complexes, H-for HMGA complexes or G-for the GATAβ-attributed complex. Bending induced on pL1 and pL9 by wild-type BmHMGA (wt.) and deletion mutants (mut1-mut5). The relative mobility of permuted promoter fragments after binding of each protein is depicted in simple plots. The wt 'curve' was not produced by any of the deletion mutants tested. different among the αL9 restriction fragments, but was almost identical for βL9 ones, signifying bending within the pL9 α-half, as predicted above. Finally, apparent bending angles were calculated according to the μM/μE = cos α / 2 formula [24] ; they differed for each promoter, probably also due to the difference in BmHMGA binding sequence spacing. In the case of pL9, an angle of 95
• was calculated, and for pL1 the angle was 87
• . We also proceeded with the expression and purification of five deletion mutants of BmHMGA (Figure 1 ). In these fusion proteins, certain key domains were deleted (one or more AThook motifs and/or the full length or part of the acidic region) and bending assays were repeated. Mutants bearing at least two AT-hook motifs bound DNA fragments with affinity comparable with that of the full-length protein. BmHMGAmut5, containing a single AT-hook, could also bind DNA, but with lower affinity (results not shown). Relative complex mobilities were plotted as simple graphs representing the observed 'curve' (Figure 7) . Curves generated by the interaction of full-length BmHMGA with the permuted fragments could not be reproduced upon addition of any deletion mutant. Significant differences in DNA contortion and, in some cases, preclusion of DNA bending were observed. Progressive deletion of functional motifs in the protein mutants did not result in the loss of 'curving' ability in a linear manner. It should be noted that the effect of binding of the same mutant to either promoter resulted in similar DNA contortion. These findings suggest that the full-length molecule is required in order to bend DNA efficiently.
BmHMGA develops interaction with other choriogenic transcriptional regulators
The very first evidence for synergy between BmC/EBP and BmHMGA was derived from gel retardation assays using follicular nuclear extracts ( Figure 5A ). The respective recombinant factors were allowed to interact with the pL9 fragment, either consecutively or simultaneously ( Figure 5B ). The DNA-protein complexes produced migrated through the gel more slowly than complexes resulting from BmC/EBP (complex C2, corresponding to the X2 complex of Figure 5A) or BmHMGA (complex H). When added to the reaction in a consecutive manner (15 min of incubation with BmC/EBP, addition of BmHMGA in equimolar quantity, followed by another 15 min of incubation) formation of two distinct complexes (C/H1 and C/H2) was observed. However, when the two factors were allowed to interact on ice for 10 min and then added on to the promoter probe, a single complex (C/H3) of further diminished mobility was generated. Since these two proteins do not compete for the same or overlapping binding elements, we presume a synergistic mode of action.
We sought to verify their ability to interact in a eukaryotic cell context through yeast two-hybrid interaction assays. Fulllength ORFs were cloned into 'prey' and 'bait' vectors and were tested for interaction in alternating pairs. Pairs resulted in comparable amounts of relative interaction, compared with the positive interaction control ( Figure 8A ). Results were highly reproducible, and interaction values were always distinctly higher than those of the negative control, the interaction of BmHMGA with the Cotesia congregata bracovirus protein CcV1 (GenBank ® accession number CAG17443).
Since chorion genes are developmentally regulated, we would expect transcription factors to interact differentially in vivo. This question was pursued by conducting co-IP (co-immunoprecipitation) assays on protein extracts from staged follicular nuclei ( Figure 8B ). co-IPs were carried out using anti-HMGI/Y, raised against human HMGA [15] or the C135 antiserum raised against Drosophila C/EBP [36] or finally the NT2-102 antiserum recognizing BmGATAβ [10] . For the first two, extracts from developmental stages were evenly combined: Pre, E and EM, M and ML, L and VL, thus representing vitellogenesis, E, M and L choriogenesis respectively. For the L-activator BmGATAβ, we combined vitellogenic and E choriogenic extracts. We showed that BmHMGA and BmC/EBP interact in the follicular nucleus, regardless of developmental stage, but in an evidently more prominent fashion during E and M choriogenesis. In the co-IP between BmGATAβ and BmHMGA, interaction was only observed during L choriogenesis, when the factor is supposed to be implicated in L chorion gene activation [8] . Control blots using (i) the secondary anti-rabbit IgG (HRP-conjugated) antibody alone, (ii) total cytoplasmic protein extracts as the co-IP input, or (iii) the non-specific C/EBPδ antiserum for the co-IP yielded no detectable signals ( Figure 8B ). BmHMGA therefore develops a developmentally defined pattern of interaction with these modulators of chorion gene expression.
The amino acid sequence encompassing the third AT-hook motif of BmHMGA is sufficient for interaction with BmC/EBP
In an attempt to map the interaction domain of BmHMGA with BmC/EBP, we performed in vitro protein-protein cross-linking Co-IP assays using staged follicular nuclear extracts (Pre-VL stages). Protein samples precipitated using C/EBP, HMGA or BmGATAβ antisera were separated by gradient SDS/PAGE; stage-specific interactions were visualized via Western blots. 'Input' lanes represent 20 % of the actual input. Cytoplasmic protein extracts (cyt.) that underwent the same procedure were used as a control. Additional control assays using the non-specific C/EBPδ antiserum are grouped below. Positions of the protein ladder are indicated on the right. (C) Mapping of the BmHMGA interaction domain via chemical cross-linking. BmHMGA (arrowhead) was allowed to interact with BmC/EBPγ (panel 1) and BmC/EBP (circle; panel 2), and complexes were cross-linked using BS 3 . HMGA deletion mutants 2 and 5 (arrowhead; panels 3 and 4 respectively) underwent the same procedure. For Western blots, an anti-His 6 monoclonal antibody was used; interaction is indicated by the presence of a ∼ 50 kDa complex (circle/arrowhead). For the non-specific interaction control, BmC/EBPγ and BmHMGA having almost identical mobility in SDS/16 % PAGE appear as a single intense band (panel 1). Positions of indicative bands of the protein ladder are shown. (D) ChIP conducted on chromatin from consecutive developmental stages (Pre-VL) using antibodies against BmHMGA, BmC/EBP, BmGATAβ and TFIID/TBP and testing for A /B.L9 and A /B.L1 gene promoter amplification; input samples are shown. As controls, no antibody (no Ab) and non-specific antibody (anti-C/EBPδ) reactions were used.
assays; the chemical cross-linker used was BS 3 , bearing a spacer arm of 11.4 Å (1 Å = 0.1 nm). Equimolar quantities of the interacting counterparts were allowed to interact, and samples were cross-linked by the addition of BS 3 ; formed complexes were identified with the use of a monoclonal antibody raised against the six N-terminal histidine residues of the recombinant proteins ( Figure 8C ). Using the full-length recombinant protein and deletion mutants 2 (lacking the regions encompassing AT-hook motif 1 and 4, as well as the acidic C-terminus) and 5 (consisting of the region encompassing the third AT-hook), we discovered that an approx. 50 kDa complex representing pairing of BmHMGA and BmC/EBP could be formed. These findings suggest that interaction does not require the involvement of the acidic tail of BmHMGA, nor any of the first, second and fourth AT-hooks. In contrast, the 37-amino-acid-long sequence encompassing the third AT-hook forms a scaffold that suffices for interaction with BmC/EBP. In control reactions, proteins did not form selfaggregates; in the non-specific interaction between BmHMGA and BmC/EBPγ (GenBank ® accession number AY618900), no complex could be stabilized, thus supporting assay specificity.
BmHMGA, BmC/EBP, BmGATAβ and TFIID are differentially recruited to chorion gene promoters
ChIP was applied on to nuclei from staged follicles, in order to assess M chorion gene promoter occupancy by transcription factors during ovarian development. We looked for binding of BmHMGA, BmGATAβ and the transcription initiation factor TFIID/ TBP (TATA-box-binding protein) on A/B.L1 and A/B.L9 gene pair promoters ( Figure 8D ; lanes concerning BmC/EBP have been discussed recently [10] and are included for correlation purposes).
BmHMGA was found to be pre-loaded on to both promoters, already from vitellogenesis, but not uniformly. It bound with noticeably higher affinity to its cognate elements in stages EM to ML; lower signals came from vitellogenic and VL choriogenic stages. On the other hand, BmGATAβ binding was prominent during M, absent during ML and detectable in L/VL stages. Very faint signals from vitellogenic and E/EM choriogenic stages are in agreement with observations from E chorion gene promoter studies [21] . As far as TFIID was concerned, its binding profile fitted the transcriptional profile of the studied gene pairs (A/B.L9 displaying shorter and earlier expression than A/B.L1) and indicated orderly recruitment of the general transcriptional machinery. Finally, BmC/EBP could not be positioned on either promoter in vitellogenesis, but occupied sites on both during choriogenesis. Binding to L1 promoter took place at a slightly later time during follicle development than binding to L9. Our results also showed evident rebinding of BmC/EBP during L choriogenesis, when the respective genes were expected to be transcriptionally silenced. The anti-C/EBPδ (non-specific control) and 'no antibody' control reactions generated no significant background signals.
BmHMGA and BmC/EBP are involved in the regulation of both the BmC/EBP and chorion genes
Taking advantage of the fact that B. mori ovarioles retain their ability to develop independently outside the living organism [37] , the in vivo role of BmHMGA was investigated using antisense DNA interference assays. A short antisense oligonucleotide complementing 20 bp around the initiation codon of the BmHMGA transcript was found to transiently block gene expression. We isolated vitellogenic (Series A) and E choriogenic (Series B) follicles and allowed them to develop in a favourable medium. RT-PCR on mRNA isolated from the follicles revealed a specific decrease in BmHMGA transcripts, which in turn affected chorion gene expression levels ( Figure 9A ). In more detail, Series A follicles progressed up to E choriogenesis and BmHMGA repression led to an obvious diminishment of ErA.1 gene transcription. Series B follicles progressed until M choriogenesis. In this case, BmHMGA transcripts were also reduced, resulting in analogous down-regulation of B.L11 expression. In both series, the actin control displayed uniform levels of expression, and PCRs seeking to amplify Hc.A/B genes generated no product (results not shown). The latter is indicative of the fact that follicles of either series did not progress into L choriogenesis, when this group of genes is rigorously transcribed. Mock Series C showed prominent and uniform expression levels of all amplified gene targets ( Figure 9A ), confirming specific targeting of the antisense oligonucleotide.
Interestingly, diminishment of BmHMGA transcript abundance affected BmC/EBP transcription, with a noticeable decrease in BmC/EBP transcripts observed (especially in Series A). In the light of this finding, we investigated the in vivo occupancy of the BmC/EBP putative promoter region by transcription factors BmC/EBP, BmHMGA, BmGATAβ and TFIID/ TBP. We used the sequences included in the B. mori genomic database (http://sgp.dna.affrc.go.jp/) and identified a candidate promoter region spanning approx. 3 kb upstream of the BmC/EBP transcription initiation site. Specific primers were designed encompassing positions − 159 to − 639 and − 1096 to − 1599; these two regions were termed proximal promoter (pp) and distal promoter (dp) respectively. We chose the pp and dp fragments because they contained recognition elements for BmHMGA as well as BmC/EBP and BmGATAβ. The dp was the sole region containing a typical TATA box sequence, whereas in the − 159 to − 1 region, all three recognition elements were not identified.
ChIP assays revealed distinct differences between the putative promoter regions. In dp, no binding of either factor could be detected, not even TFIID/ TBP, despite the presence of a TATA box (results not shown). On pp, however, all factors presented specific binding profiles ( Figure 9B ). BmHMGA was located on the amplified fragment from E to ML/L choriogenic stages, BmC/EBP in E and EM stages, when the gene is rigorously transcribed, and BmGATAβ binding was evident solely during L stages; recruitment of TFIID took place in E choriogenesis. This may be explained under the assumption that TFIID/ TBP on this potential TATA-less promoter is required only for initiating transcription, but not for maintaining an active state of gene expression.
Lastly, ChIP assays were performed on follicles (Series B) grown to mid-choriogenic stages in the presence of an antisense oligonucleotide against BmHMGA. We noticed that binding of HMGA to L9 promoter is a prerequisite for C/EBP recruitment ( Figure 9C) ; recruitment of BmGATAβ and TFIID/ TBP was also evidently impeded. Assays were repeated on chromatin isolated from follicles treated with an antisense oligonucleotide targeting BmC/EBP [10] and similar results were obtained. Abolishing BmC/EBP binding to L9 promoter resulted in non-recruitment of TFIID/ TBP. Binding of BmHMGA, however, was not hindered, and neither was BmGATAβ binding ( Figure 9C ). Results were the same for both L1 and pp promoter fragments (results not shown).
DISCUSSION
In general, binding of proteins classified under the HMGA subfamily to DNA induces bending of specific magnitude. Their interaction with promoter/enhancer sequences and participation in multi-protein complexes is of definitive importance for orderly recruitment of transcription factors and of the general transcription machinery [28, 38] . In the present study, we isolated a gene coding for an HMGA-like protein from the developing follicular epithelium of B. mori. The primary protein structure of this factor contains characteristic HMGA motifs. The protein, accordingly named BmHMGA, is distinguishable from other insect and mammalian orthologues because of the unique presence of a fourth AT-hook. In addition, the B. mori protein does not undergo alternative splicing, at least in follicular cells, unlike mammalian HMGA1 genes. BmHMGA transcripts accumulate in follicular cells throughout oogenesis, and distinct peaks of transcription were observed during L vitellogenesis, and M and L-VL choriogenesis.
B. mori HMGA recognizes and binds specifically to chorion gene promoters, regardless of their developmental specificity. Binding occurs via the AT-hooks of the protein and is of specific nature. Our footprinting data suggest that binding occurs on two adjacent sequences that are phased on the DNA helix. We propose further that a single molecule occupies both sites via two AT-hooks. The AT-hook pair most likely to engage in DNA binding encompasses the first two consecutive motifs, as in the deletion mutants tested, this pair (in the presence of the acidic C-terminus) conveyed full functionality. A direct consequence of BmHMGA binding to DNA is induction of bending. Binding of an architectural protein to DNA is known to contribute towards the stabilization of intermolecular complexes [39, 40] and ultimately leads to a single reproducible conformation [16] . Our circular permutation assays revealed specific contortion of M chorion gene promoters of approx. 90
• ; the bend centres were in both cases located in the spacer sequence between the two binding elements of BmHMGA. The full-length protein is required for inducing a specific angle, as use of BmHMGA deletion mutants in bending Figure 9 BmHMGA and BmC/EBP regulate both BmC/EBP and chorion gene expression (A) Antisense DNA interference assays. Electrophoretic analysis of PCR products amplified using the BmHMGA antisense assay cDNA pool as template. Amplification of the BmHMGA, BmC/EBP and ErA .1 transcripts from Series A follicles grown in the absence (0 μM) or presence (5-25 μM) of the antisense oligonucleotide; B.L11 transcription was not initiated in this series. In follicles from Series B, amplification of BmHMGA, BmC/EBP and B.L11 transcripts grown in the absence (0 μM) or presence (5-20 μM) of the antisense oligonucleotide is shown; ErA .1 transcription has been terminated, as these are more mature follicles. In the mock control set-up of the assay, the BmHMGA, BmC/EBP and ErA .1 transcripts were amplified. In all three series, lanes C represent no template reactions; actin A3 transcript amplification was used as a control of specific antisense targeting; markers used were 100 bp and 1 kb ladders (Fermentas) and PCR marker (Promega). (B) ChIP assays on the BmC/EBP putative promoter. ChIP conducted on chromatin from consecutive developmental stages (Pre-VL) using antibodies against BmHMGA, BmC/EBP, BmGATAβ and TFIID/TBP; input samples are shown. As controls, a no-antibody (no Ab) and non-specific antibody (anti-C/EBPδ) reactions were used. In the graphic representing cis-element content of the BmC/EBP proximal promoter, oval shapes denote C/EBP, triangles GATA and boxes HMGA sites. assays generated less sharp angles. We suggest that the functional purpose of HMGA-mediated DNA bending is deployment of protein-protein interaction for activation of transcription of both α-and the β-gene by a single short promoter of 250 bp. The α-half of the studied region seems to cluster most necessary ciselements for gene activation, and this is supported by data from assays where this segment was capable of driving quantitative and qualitative expression of reporter genes [41] .
BmHMGA interacts physically with BmC/EBP during choriogenesis for synergistic binding, until this interaction fades in VL chorion stages when the developmental cascade concludes. BmC/EBP possesses a dual role in chorion gene regulation. Its binding profile on chorion gene promoter modules provides evidence for its implication in the onset of transcription as well as in the establishment of repression [10] . We showed that BmC/EBP recruitment to both A/B.L1 and A/B.L9 promoters is dependent on interaction with BmHMGA, their recognition elements being positioned adjacent to one another. Impeding recruitment of BmC/EBP leads to non-recruitment of TFIID/ TBP in the promoter vicinity. BmHMGA also interacts with BmGATAβ, a protein proposed initially to act as a L-specific activator [8, 42] , but later also implicated in E chorion promoter binding [21] . GATA factors in general may undertake the role of a repressor [43] , of an activator [44] or even a biphasic role dependent on protein availability [45] . We provided data of its interaction with BmHMGA only during L choriogenesis, presumably for activating L (HcA/B) genes. ChIP assays revealed a peculiar binding profile of BmGATAβ on M chorion gene promoters in M and in L/VL stages. Its recruitment to A/B.L1 and A/B.L9 promoters depends on its interaction with BmHMGA, but not BmC/EBP. Although we cannot exclude its involvement in A/B.L1 and A/B.L9 activation, we strongly support a scheme according to which BmGATAβ in an antagonistic relation to BmC/EBP imposes their repression.
In view of these findings, we propose a regulatory role for BmHMGA in terms of intercalation in the BmC/EBP-BmGATAβ functional equilibrium towards maintaining the developmental programme of chorion gene expression (Figure 10 ). This architectural factor is pre-loaded on chorion promoters from vitellogenesis and mediates BmC/EBP binding. Following temporal-specific TFIID/ TBP recruitment by BmC/EBP, the formation of higher-order complexes on pL1 and pL9 should facilitate assembly of the general transcription machinery. BmC/EBP in turn detaches, and interaction is reinstated when repression is to be established. However, a L-specific interaction of BmHMGA with BmGATAβ may act as the intermediate signal for down-regulation of M chorion genes. Under this scenario, BmHMGA acts a hub where different modes of proteinprotein interaction initiate, terminate and establish arrest of chorion gene expression. In our opinion, induction of DNA bending contributes in the direction of facilitating deployment of such interaction and is probably a feature of functional importance for proper follicle development. Furthermore, there seems to be a transcriptional circuit (Figure 10 ) through which the BmC/EBP gene is self-and hetero-regulated and which in turn affects chorion gene expression; self regulation of C/EBP genes is common in eukaryotes [46] . On the basis of the present study, we support the scenario that BmHMGA and BmC/EBP co-regulate transcription of the latter in a positive manner, whereas BmGATA antagonizes BmC/EBP for interaction with BmHMGA during L choriogenesis, binds to its cognate elements and potentially signals transcriptional repression. Attenuating BmC/EBP expression gradually results in the down-regulation of chorion genes (at least E-and M-type genes). In all of the above processes, BmHMGA assumes a mediator role and seems to coordinate the deployment of protein-protein interaction towards orchestrated gene expression.
